Evidence map›Paper›PMID 40477682›Full record

ArticleUrban forum (Johannesburg, South Africa)2022

Reaching High: Translating Emergent Practices of Street-Level Drug Users to Institute Harm Reduction in Durban-Implications for Urban Governance.

Monique Marks, Sogen Moodley

Abstract read
In one paragraph

Article in Urban forum (Johannesburg, South Africa), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Monique MarksUrban Futures Centre, Durban University of Technology, Steve Biko Campus, Steve Biko Road, Durban, 4001 South Africa.ORCID 0000-0002-4926-6972
Sogen MoodleyUrban Futures Centre, Durban University of Technology, Steve Biko Campus, Steve Biko Road, Durban, 4001 South Africa.ORCID 0000-0002-9885-0040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Problematic drug use is a growing problem in South African urban spaces. In Durban, as in other cities in the country, the dominant response of the capital-oriented Municipality has been to make drug use invisible through prohibition and a promotion of abstinence approaches. This governance mentality and technology has failed dismally, evidenced in the rise of street-level heroin use. During the COVID-19 hard lockdown, the municipality was forced to re-examine its governance approach to drug use, taking guidance from non-state actors in an attempt to more effectively reduce the harms associated with drug use. In tracing the historical contestations around street-level drug use in Durban, this paper shares the untold story of how, when prompted by an unforeseen crisis, a municipality was able to successfully shift its mentality and technology in governing street-level drug use. Drawing conceptually on nodal governance theory and the quadruple helix approach, it reveals the complexities of urban governance processes and demonstrates the power of political opportunities, the transformative role of unexpected consequences, and the importance of informed political leadership. It also shows how multi-stakeholder partnership projects can be a useful mechanism not only to implement innovative and creative policy goals, but also to build robust relationships to navigate the manifestation of informal urbanism. It also calls for governing through harm minimisation rather than through actuarial risk management approaches that are closely associated with a neoliberal agenda.

Indexed as

Harm reductionNodal governanceQuadruple helixStreet-level drug useUrban governance

Identifiers

PMID40477682
PMCPMC8592825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.